The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia

The TA-isoform of the p63 transcription factor (TAp63) has been reported to contribute to clinical aggressiveness in chronic lymphocytic leukemia (CLL) in a hitherto elusive way. Here, we sought to further understand and define the role of TAp63 in the pathophysiology of CLL. First, we found that el...

Descripción completa

Detalles Bibliográficos
Autores principales: Laidou, Stamatia, Grigoriadis, Dionysios, Papanikolaou, Sofia, Foutadakis, Spyros, Ntoufa, Stavroula, Tsagiopoulou, Maria, Vatsellas, Giannis, Anagnostopoulos, Achilles, Kouvatsi, Anastasia, Stavroyianni, Niki, Psomopoulos, Fotis, Makris, Antonios M., Agelopoulos, Marios, Thanos, Dimitris, Chatzidimitriou, Anastasia, Papakonstantinou, Nikos, Stamatopoulos, Kostas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043946/
https://www.ncbi.nlm.nih.gov/pubmed/35235952
http://dx.doi.org/10.1182/bloodadvances.2021006348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043946/
https://www.ncbi.nlm.nih.gov/pubmed/35235952
http://dx.doi.org/10.1182/bloodadvances.2021006348

Ejemplares similares